BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25564398)

  • 1. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
    Kocher F; Hilbe W; Seeber A; Pircher A; Schmid T; Greil R; Auberger J; Nevinny-Stickel M; Sterlacci W; Tzankov A; Jamnig H; Kohler K; Zabernigg A; Frötscher J; Oberaigner W; Fiegl M
    Lung Cancer; 2015 Feb; 87(2):193-200. PubMed ID: 25564398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment.
    Al-Shamsi HO; Al Farsi A; Ellis PM
    Clin Lung Cancer; 2014 Jul; 15(4):274-80. PubMed ID: 24685356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSCLC without Antineoplastic Treatment: Incidence, Characteristics, and Outcome as Outlined in the TYROL Study.
    Kocher F; Lunger F; Pircher A; Hilbe W; Fiegl M
    Oncology; 2015; 89(5):255-61. PubMed ID: 26303584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
    Mauri D; Pentheroudakis G; Bafaloukos D; Pectasides D; Samantas E; Efstathiou E; Kalofonos HP; Syrigos K; Klouvas G; Papakostas P; Kosmidis P; Fountzilas G; Pavlidis N;
    Anticancer Res; 2006; 26(4B):3175-81. PubMed ID: 16886653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of stage I non-small cell lung cancer: implications for early detection.
    Raz DJ; Zell JA; Ou SH; Gandara DR; Anton-Culver H; Jablons DM
    Chest; 2007 Jul; 132(1):193-9. PubMed ID: 17505036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
    Vinod SK; Chandra A; Berthelsen A; Descallar J
    Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and survival from lung cancer in Greenland is comparable to survival in the Nordic countries.
    Gelvan A; Risum S; Langer SW
    Dan Med J; 2015 Apr; 62(4):A5033. PubMed ID: 25872548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Simplified Comorbidity Score (Colinet) as a prognostic indicator for patients with lung cancer: a cancer registry study.
    Ball D; Thursfield V; Irving L; Mitchell P; Richardson G; Torn-Broers Y; Wright G; Giles G
    Lung Cancer; 2013 Nov; 82(2):358-61. PubMed ID: 24051083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
    Su S; Li T; Lu B; Wang X; Li J; Chen M; Lu Y; Bai Y; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):769-77. PubMed ID: 26530745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
    Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
    J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
    Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
    Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
    Sher DJ; Koshy M; Liptay MJ; Fidler MJ
    Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.
    Johnson AM; Hines RB; Johnson JA; Bayakly AR
    Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients.
    Driessen EJ; Aarts MJ; Bootsma GP; van Loon JG; Janssen-Heijnen ML
    Lung Cancer; 2017 Jun; 108():198-204. PubMed ID: 28625635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?
    Choi YW; Ahn MS; Jeong GS; Lee HW; Jeong SH; Kang SY; Park JS; Choi JH; Lee SY
    Lung Cancer; 2015 Feb; 87(2):155-61. PubMed ID: 25488862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
    Wakelee HA; Bernardo P; Johnson DH; Schiller JH
    Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.